Specification

MSDS

TSE / BSE Statement

Retest Statement

• compounds, methods, receptor, compositions, inhibitors, adrenergic receptor, farnesyl transferase, farnesyl, transferase, adrenergic, restenosis, pharmaceutical, formula, protein, diabetes, type 2 diabetes, cancer, mellitus, derivatives, atherosclerosis, pharmaceutical compositions, method, compound, β2 adrenergic, β2 adrenergic receptor, psoriasis, recording, agonist, prediabetes, Show more, composition metabolic, receptor agonist, agonists, metabolic syndrome, syndrome, receptor agonists, intermediates, enzymes, activity, diseases, receptor activity, preparation, endometriosis, viral infections, alkyl, infections, viral, functionalized, adrenergic receptor agonist, alkenyl, chain, transferase inhibitors, farnesyl transferase inhibitors, farnesyltransferase, hydrogen, pharmaceutical composition, nitrogen, solid, control, orally, solid dosage, children, dosage formulations, humans, formulations, adolescents, dosage, weight, structure, amino, ketones, nitrogen atom, β2-adrenergic, chronic, specific, β2-adrenergic receptor, dipeptide, effect, inhibition, beta2-adrenergic receptor, disease, 2-adrenergic receptor, reaction, substituted, peroxide, glycinamide, solution, absorption, amines, piperidine, chains, ammonium, water soluble polymer, specific type, class, heteroaryl ring, dipropylamine, agonistic effect, carbon atom, tributylamine, soluble polymer, triethylamine, pulmonary disease, hydrogen peroxide, quinuclidine, cancer chemotherapy, lung disease, vanadium, Show less